A Study to Evaluate VIB7734 in Participants With Systemic Lupus Erythematosus (SLE), Cutaneous Lupus Erythematosus (CLE), Sjogren's Syndrome, Systemic Sclerosis, Polymyositis, and Dermatomyositis

Conditions:   Systemic Lupus Erythematosus;   Cutaneous Lupus Erythematosus;   Sjogren's Syndrome;   Systemic Sclerosis;   Polymyositis;   Dermatomyositis Interventions:   Drug: VIB7734;   Drug: Placebo Sponsor:   Viela Bio Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials